Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

PhD Mojca Lunder

PhD Mojca Lunder
no.: 25096 source: ARIS

researcher – active in research organisation
mojca.lunderat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
274.98
A''
80.19
A'
132.89
A1/2
132.89
CI10
550
CImax
119
h10
13
A1
0.96
A3
1.02
Data for the last 5 years (citations for the last 10 years) on April 17, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 50  677  563  11.26 
Scopus 52  759  649  12.48 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2008 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Title ecris.org.employ_rolegroup
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  12/1/2003    Full professor  Researcher 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking   2023 - 2024  PhD Peter Korošec  1,399 
2. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   2021 - 2024  PhD Borut Štrukelj  3,034 
3. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2   2020 - 2022  PhD Roman Jerala  8,216 
4. J4-1767  Selective extraction of high value molecules from forest products processing residues in the speciality chemicals sector   2019 - 2022  PhD Andreja Kutnar  4,052 
5. J3-5502  Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration   2013 - 2016  PhD Boris Rogelj  5,275 
6. J3-4026  Transport and RNA binding of TDP-43 and FUS - implications for ALS/FTLD spectrum of neurodegenerative disease   2011  PhD Boris Rogelj  4,609 
7. L4-1046  NOVEL BIOTECH DRUG SUBSTANCES BY USING PHAGE DISPLAY TECHNOLOGY   2008 - 2011  PhD Borut Štrukelj  3,938 
8. L3-0129  Cell-free nucleic acids in diagnosis of coronary atherosclerosis   2008  PhD Darko Černe  2,042 
9. J3-0488  Functional analysis of non-coding RNAs in Parkinson's disease   2008  PhD Boris Rogelj  2,338 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy   2022 - 2024  PhD Žiga Jakopin  1,240 
2. P4-0127  Pharmaceutical biotechnology: Science for health   2019 - 2021  PhD Janko Kos  5,044 
3. P4-0127  Pharmaceutical biotechnology: Science for Health   2015 - 2018  PhD Janko Kos  4,938 
4. P4-0127  Farmacevtska biotehnologija: znanje za zdravje (Slovene)   2009 - 2014  PhD Janko Kos  5,413 
5. P4-0127  Pharmaceutical biotechnology: man and environment   2007 - 2008  PhD Janko Kos  5,244 
Confirmation required
Views history
Favourite